Here’s the Scoop on the Biggest Healthcare SPAC Deal So Far

Let’s look at why a consumer genomics leader has finally decided to go public.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.